Articles
Role of Human Infection Challenge Studies (HICs) in Drug Development for Respiratory Syncytial Virus (RSV)
HICs are vital for RSV drug development, providing crucial insights into viral load and symptoms to accelerate new treatments.
Human infection challenge studies (HICs) are powerful in establishing early proof-of-concept for experimental drugs and understanding disease pathogenesis. A comprehensive assessment of HICs will allow to understand the viral load (VL) dynamics and symptom score kinetics of respiratory syncytial virus (RSV) and facilitate drug development for RSV.
Click here to access the article.